Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.

IF 1.6 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Ryohei Ono, Luiz Menezes Falcão
{"title":"Primary heart failure with preserved ejection fraction: The intertwined pathophysiology and treatment of some of the most relevant phenotypes.","authors":"Ryohei Ono, Luiz Menezes Falcão","doi":"10.1016/j.repc.2025.02.007","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure with preserved ejection fraction (HFpEF) is characterized by diverse underlying pathophysiological mechanisms and can be divided into two subgroups based on the identification of the specific cause: primary and secondary HFpEF. Primary HFpEF is caused by primary impairments in myocardial relaxation or compliance with the contribution of several risk factors. Therefore, we review current literature on pathophysiology and treatment in patients with primary HFpEF. Patients with primary HFpEF represent specific \"phenotypes\" and are usually elderly, more commonly women, and often with a history of arterial hypertension, obesity, iron deficiency (ID), coronary artery disease (CAD), sleep apnea, diabetes, chronic kidney disease (CKD), and chronotropic incompetence. Some of the main pathophysiological mechanisms for each phenotype of primary HFpEF are as follows: arterial hypertension, which promotes left ventricular hypertrophy and fibrosis; obesity, which contributes through systemic inflammation and metabolic dysregulation; aging, which leads to ventricular-vascular stiffening; gender differences, with women experiencing changes due to smaller heart size and hormonal shifts; ID, which affects mitochondrial function; CAD, which impairs myocardial blood flow; diabetes, which is associated with hyperglycemia, lipotoxicity, insulin resistance, and microvascular rarefaction; CKD, which leads to hypertension, metabolic disturbance, systemic inflammation, and endothelial dysfunction; sleep apnea, which induces cardiac changes through pressure swings and hypoxia; and chronotropic incompetence, which is due to reduced cardiac β-receptor responsiveness. In conclusion, each factor intricately contributes to the complex pathophysiology of HFpEF. Understanding these interrelated mechanisms is critical for tailoring management strategies to improve outcomes in HFpEF patients.</p>","PeriodicalId":48985,"journal":{"name":"Revista Portuguesa De Cardiologia","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Portuguesa De Cardiologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.repc.2025.02.007","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure with preserved ejection fraction (HFpEF) is characterized by diverse underlying pathophysiological mechanisms and can be divided into two subgroups based on the identification of the specific cause: primary and secondary HFpEF. Primary HFpEF is caused by primary impairments in myocardial relaxation or compliance with the contribution of several risk factors. Therefore, we review current literature on pathophysiology and treatment in patients with primary HFpEF. Patients with primary HFpEF represent specific "phenotypes" and are usually elderly, more commonly women, and often with a history of arterial hypertension, obesity, iron deficiency (ID), coronary artery disease (CAD), sleep apnea, diabetes, chronic kidney disease (CKD), and chronotropic incompetence. Some of the main pathophysiological mechanisms for each phenotype of primary HFpEF are as follows: arterial hypertension, which promotes left ventricular hypertrophy and fibrosis; obesity, which contributes through systemic inflammation and metabolic dysregulation; aging, which leads to ventricular-vascular stiffening; gender differences, with women experiencing changes due to smaller heart size and hormonal shifts; ID, which affects mitochondrial function; CAD, which impairs myocardial blood flow; diabetes, which is associated with hyperglycemia, lipotoxicity, insulin resistance, and microvascular rarefaction; CKD, which leads to hypertension, metabolic disturbance, systemic inflammation, and endothelial dysfunction; sleep apnea, which induces cardiac changes through pressure swings and hypoxia; and chronotropic incompetence, which is due to reduced cardiac β-receptor responsiveness. In conclusion, each factor intricately contributes to the complex pathophysiology of HFpEF. Understanding these interrelated mechanisms is critical for tailoring management strategies to improve outcomes in HFpEF patients.

原发心力衰竭与保留射血分数:交织病理生理和治疗的一些最相关的表型。
保留射血分数(HFpEF)心力衰竭具有多种潜在的病理生理机制,根据具体原因的确定可分为两个亚组:原发性和继发性HFpEF。原发性HFpEF是由心肌舒张或依从性的原发性损伤引起的,有几种危险因素的影响。因此,我们回顾了目前关于原发性HFpEF患者的病理生理和治疗的文献。原发性HFpEF患者具有特定的“表型”,通常为老年人,更常见的是女性,并且通常有动脉高血压、肥胖、缺铁(ID)、冠状动脉疾病(CAD)、睡眠呼吸暂停、糖尿病、慢性肾脏疾病(CKD)和变时功能不全的病史。原发性HFpEF各表型的一些主要病理生理机制如下:动脉高血压,促进左心室肥厚和纤维化;肥胖,导致全身性炎症和代谢失调;衰老,导致心室血管硬化;性别差异,女性由于心脏尺寸较小和荷尔蒙变化而经历变化;ID,影响线粒体功能;CAD,损害心肌血流;糖尿病,与高血糖、脂肪毒性、胰岛素抵抗和微血管稀疏有关;CKD,导致高血压、代谢紊乱、全身炎症和内皮功能障碍;睡眠呼吸暂停,通过压力波动和缺氧引起心脏变化;以及变时功能不全,这是由于心脏β受体反应性降低所致。总之,每个因素都复杂地参与了HFpEF的复杂病理生理。了解这些相互关联的机制对于调整管理策略以改善HFpEF患者的预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista Portuguesa De Cardiologia
Revista Portuguesa De Cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.70
自引率
22.20%
发文量
205
审稿时长
54 days
期刊介绍: The Portuguese Journal of Cardiology, the official journal of the Portuguese Society of Cardiology, was founded in 1982 with the aim of keeping Portuguese cardiologists informed through the publication of scientific articles on areas such as arrhythmology and electrophysiology, cardiovascular surgery, intensive care, coronary artery disease, cardiovascular imaging, hypertension, heart failure and cardiovascular prevention. The Journal is a monthly publication with high standards of quality in terms of scientific content and production. Since 1999 it has been published in English as well as Portuguese, which has widened its readership abroad. It is distributed to all members of the Portuguese Societies of Cardiology, Internal Medicine, Pneumology and Cardiothoracic Surgery, as well as to leading non-Portuguese cardiologists and to virtually all cardiology societies worldwide. It has been referred in Medline since 1987.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信